Non-Occlusive Mesenteric Ischemia in Children With Diabetic Ketoacidosis: Case Report and Review of Literature

IntroductionDespite the use of technology, recurrent diabetic ketoacidosis (DKA) prevention remains an unmet need in children and adolescents with T1D and may be accompanied by life-threatening acute complications. We present a rare case of non-occlusive mesenteric ischemia (NOMI) with overt manifestation after DKA resolution and a discussion of recent literature addressing DKA-associated NOMI epidemiology and pathogenesis in children and adolescents.Case PresentationA 13-year-old female with previously diagnosed T1D, was admitted at our emergency department with hypovolemic shock, DKA, hyperosmolar state and acute kidney injury (AKI). Mildly progressive abdominal pain persisted after DKA correction and after repeated ultrasound evaluations ultimately suspect for intestinal perforation, an intraoperative diagnosis of NOMI was made.ConclusionThe diagnosis of DKA-associated NOMI must be suspected in pediatric patients with DKA, persistent abdominal pain, and severe dehydration even after DKA resolution

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis

We analyzed whether serum albumin is independently associated with portal vein thrombosis (PVT) in liver cirrhosis (LC) and if a biologic plausibility exists. This study was divided into three parts. In part 1 (retrospective analysis), 753 consecutive patients with LC with ultrasound-detected PVT were retrospectively analyzed. In part 2, 112 patients with LC and 56 matched controls were entered in the cross-sectional study. In part 3, 5 patients with cirrhosis were entered in the in vivo study and 4 healthy subjects (HSs) were entered in the in vitro study to explore if albumin may affect platelet activation by modulating oxidative stress. In the 753 patients with LC, the prevalence of PVT was 16.7%; logistic analysis showed that only age (odds ratio [OR], 1.024; P = 0.012) and serum albumin (OR, -0.422; P = 0.0001) significantly predicted patients with PVT. Analyzing the 112 patients with LC and controls, soluble clusters of differentiation (CD)40-ligand (P = 0.0238), soluble Nox2-derived peptide (sNox2-dp; P < 0.0001), and urinary excretion of isoprostanes (P = 0.0078) were higher in patients with LC. In LC, albumin was correlated with sCD4OL (Spearman's rank correlation coefficient [r(s)], -0.33; P < 0.001), sNox2-dp (r(s), -0.57; P < 0.0001), and urinary excretion of isoprostanes (r(s), -0.48; P < 0.0001) levels. The in vivo study showed a progressive decrease in platelet aggregation, sNox2-dp, and urinary 8-iso prostaglandin F2 alpha-III formation 2 hours and 3 days after albumin infusion. Finally, platelet aggregation, sNox2-dp, and isoprostane formation significantly decreased in platelets from HSs incubated with scalar concentrations of albumin. Conclusion: Low serum albumin in LC is associated with PVT, suggesting that albumin could be a modulator of the hemostatic system through interference with mechanisms regulating platelet activation

Role of HNFA1 Gene Variants in Pancreatic Beta Cells Function and Glycaemic Control in Young Individuals with Type 1 Diabetes

The HNF1A transcription factor, implicated in the regulation of pancreatic beta cells, as well as in glucose and lipid metabolism, is responsible for type 3 maturity-onset diabetes of the young (MODY3). HNF1A is also involved in increased susceptibility to polygenic forms of diabetes, such as type 2 diabetes (T2D) and gestational diabetes (GD), while its possible role in type 1 diabetes (T1D) is not known. In this study, 277 children and adolescents with T1D and 140 healthy controls were recruited. The following SNPs in HNF1A gene were selected: rs1169286, rs1169288, rs7979478, and rs2259816. Through linear or logistic regression analysis, we analyzed their association with T1D susceptibility and related clinical traits, such as insulin dose-adjusted glycated hemoglobin A1c (IDAA1c) and glycated hemoglobin (HbA1c). We found that rs1169286 was associated with IDAA1c and HbA1c values (p-value = 0.0027 and p-value = 0.0075, respectively), while rs1169288 was associated with IDAA1c (p-value = 0.0081). No association between HNF1A SNPs and T1D development emerged. In conclusion, our findings suggest for the first time that HNF1A variants may be a risk factor for beta cell function and glycaemic control in T1D individuals

Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients

Cirrhosis has been long considered a risk factor for bleeding due to the co-existence of the so-called \u2018coagulopathy\u2019. More recently, however, compelling evidences have been provided on the occurrence of thrombotic events in the portal and systemic circulation.3\u20135 Portal vein thrombosis (PVT) is predominantly observed in patients with moderate to severe liver failure with a variable prevalence ranging from 0.6 to 25%. Only fewstudies have provided a longitudinal assessment of the PVT incidence and its sequelae, including recurrence and survival.9\u201314 Due to the variability of PVT incidence and the paucity of data regarding recurrence and survival,15\u201320 we prospectively analysed the incidence and the recurrence of PVT in the population of Portal vein thrombosis Relevance On Liver cirrhosis: ItalianVenous thromboticEventsRegistry (PROLIVER), a multi-centre study,8 which involved 43 enrolling centres in Italy (ClinicalTrials.gov Identifier: NCT01470547)

Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation

Left ventricular hypertrophy (LVH) is significantly related to adverse clinical outcomes in patients at high risk of cardiovascular events. In patients with atrial fibrillation (AF), data on LVH, that is, prevalence and determinants, are inconsistent mainly because of different definitions and heterogeneity of study populations. We determined echocardiographic-based LVH prevalence and clinical factors independently associated with its development in a prospective cohort of patients with non-valvular (NV) AF. From the "Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study" (ARAPACIS) population, 1,184 patients with NVAF (mean age 72 \ub1 11 years; 56% men) with complete data to define LVH were selected. ARAPACIS is a multicenter, observational, prospective, longitudinal on-going study designed to estimate prevalence of peripheral artery disease in patients with NVAF. We found a high prevalence of LVH (52%) in patients with NVAF. Compared to those without LVH, patients with AF with LVH were older and had a higher prevalence of hypertension, diabetes, and previous myocardial infarction (MI). A higher prevalence of ankle-brachial index 640.90 was seen in patients with LVH (22 vs 17%, p = 0.0392). Patients with LVH were at significantly higher thromboembolic risk, with CHA2DS2-VASc 652 seen in 93% of LVH and in 73% of patients without LVH (p <0.05). Women with LVH had a higher prevalence of concentric hypertrophy than men (46% vs 29%, p = 0.0003). Logistic regression analysis demonstrated that female gender (odds ratio [OR] 2.80, p <0.0001), age (OR 1.03 per year, p <0.001), hypertension (OR 2.30, p <0.001), diabetes (OR 1.62, p = 0.004), and previous MI (OR 1.96, p = 0.001) were independently associated with LVH. In conclusion, patients with NVAF have a high prevalence of LVH, which is related to female gender, older age, hypertension, and previous MI. These patients are at high thromboembolic risk and deserve a holistic approach to cardiovascular prevention

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

In the original publication, one of the ARAPACIS collaborators Dr. “Leonardo Di Gennaro” name has been erroneously mentioned as “Leonardo De Gennaro”

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

none372In the original publication, one of the ARAPACIS collaborators Dr. “Leonardo Di Gennaro” name has been erroneously mentioned as “Leonardo De Gennaro”.noneRaparelli V.; Pastori D.; Pignataro S.F.; Vestri A.R.; Pignatelli P.; Cangemi R.; Proietti M.; Davi G.; Hiatt W.R.; Lip G.Y.H.; Corazza G.R.; Perticone F.; Violi F.; Basili S.; Alessandri C.; Serviddio G.; Palange P.; Greco E.; Bruno G.; Averna M.; Giammanco A.; Sposito P.; DeCristofaro R.; Carulli L.; DiGennaro L.; Pellegrini E.; Cominacini L.; Mozzini C.; Pasini A.F.; Sprovieri M.; Spagnuolo V.; Cerqua G.; Cerasola G.; Mule G.; Barbagallo M.; Lo Sciuto S.; Monteverde A.; Saitta A.; Lo Gullo A.; Malatino L.; Cilia C.; Terranova V.; Pisano M.; Pinto A.; DiRaimondo D.; Tuttolomondo A.; Conigliaro R.; Signorelli S.; DePalma D.; Galderisi M.; Cudemo G.; Galletti F.; Fazio V.; DeLuca N.; Meccariello A.; Caputo D.; DeDonato M.T.; Iannuzi A.; Bresciani A.; Giunta R.; Utili R.; Iorio V.; Adinolfi L.E.; Sellitto C.; Iuliano N.; Bellis P.; Tirelli P.; Sacerdoti D.; Vanni D.; Iuliano L.; Ciacciarelli M.; Pacelli A.; Palazzuoli A.; Cacciafesta M.; Gueli N.; Lo Iacono C.; Brusco S.; Verrusio W.; Nobili L.; Tarquinio N.; Pellegrini F.; Vincentelli G.M.; Ravallese F.; Santini C.; Letizia C.; Petramala L.; Zinnamosca L.; Minisola S.; Cilli M.; Colangelo L.; Falaschi P.; Martocchia A.; Pastore F.; Bertazzoni G.; Attalla El Halabieh E.; Paradiso M.; Lizzi E.M.; Timmi S.; Battisti P.; Cerci S.; Ciavolella M.; DiVeroli C.; Malci F.; DeCiocchis A.; Abate D.; Castellino P.; Zanoli L.; Fidone F.; Mannarino E.; Pasqualini L.; Oliverio G.; Pende A.; Artom N.; Ricchio R.; Fimognari F.L.; Alletto M.; Messina S.; Sesti G.; Arturi F.; Succurro E.; Fiorentino T.V.; Pedace E.; Scarpino P.E.; Carullo G.; Maio R.; Sciacqua A.; Frugiuele P.; Battaglia G.; Atzori S.; Delitala G.; Angelucci E.; Sestili S.; Traisci G.; DeFeudis L.; DiMichele D.; Fava A.; Balsano C.; DeCiantis P.; Desideri G.; Camerota A.; Mezzetti M.; Gresele P.; Vedovati C.; Fierro T.; Puccetti L.; Bertolotti M.; Mussi C.; Boddi M.; Savino A.; Contri S.; Degl'Innocenti G.; Saller A.; Fabris F.; Pesavento R.; Filippi L.; Vedovetto V.; Puato M.; Treleani M.; DeLuca E.; DeZaiacomo F.; Giantin V.; Semplicini A.; Minuz P.; Romano S.; Fantin F.; Manica A.; Stockner I.; Pattis P.; Gutmann B.; Catena C.; Colussi G.; Sechi L.A.; Annoni G.; Bruni A.A.; Castagna A.; Spinelli D.; Miceli E.; Padula D.; Schinco G.; Spreafico S.; Secchi B.; Vanoli M.; Casella G.; Pulixi E.A.; Sansone L.; Serra M.G.; Longo S.; Antonaci S.; Belfiore A.; Frualdo M.; Palasciano G.; Ricci L.; Ventrella F.; Bianco C.; Santovito D.; Cipollone F.; Nicolai S.; Salvati F.; Rini G.B.; Scozzari F.; Muiesan M.L.; Salvetti M.; Bazza A.; Picardi A.; Vespasiani-Gentilucci U.; DeVincentis A.; Cosio P.; Terzolo M.; Madaffari B.; Parasporo B.; Fenoglio L.; Bracco C.; Melchio R.; Gentili T.; Salvi A.; Nitti C.; Gabrielli A.; Martino G.P.; Capucci A.; Brambatti M.; Sparagna A.; Tirotta D.; Andreozzi P.; Ettorre E.; Viscogliosi G.; Servello A.; Musumeci M.; Delfino M.; Giorgi A.; Glorioso N.; Melis G.; Marras G.; Matta M.; Sacco A.; Stellitano E.; Scordo A.; Russo F.; Caruso A.A.; Porreca E.; Tana M.; Ferri C.; Cheli P.; Portincasa P.; Muscianisi G.; Giordani S.; Stanghellini V.; Sabba C.; Mancuso G.; Bartone M.; Calipari D.; Arcidiacono G.; Bellanuova I.; Ferraro M.; Marigliano G.; Cozzolino D.; Lampitella A.; Acri V.; Galasso D.; Mazzei F.; Buratti A.; Galasso S.; Porta M.; Brizzi M.F.; Fattorini A.; Sampietro F.; D'Angelo A.; Manfredini R.; Pala M.; Fabbian F.; Moroni C.; Valente L.; Lopreiato F.; Parente F.; Granata M.; Moia M.; Braham S.; Rossi M.; Pesce M.; Gentile A.; Catozzo V.; Baciarello G.; Cosimati A.; Ageno W.; Rancan E.; Guasti L.; Ciccaglioni A.; Negri S.; Polselli M.; Prisco D.; Marcucci R.; Ferro D.; Perri L.; Saliola M.; DelBen M.; Angelico F.; Baratta F.; Migliacci R.; Porciello G.; Corrao S.; Napoleone L.; Talerico G.; Amoroso D.; Romiti G.F.; Ruscio E.; Toriello F.; Sperduti N.; Todisco T.; DiTanna G.; Sacchetti M.L.; Puddu P.E.; Farcomeni A.; Anzaldi M.; Bazzini C.; Bianchi P.I.; Boari B.; Buonauro A.; Butta C.; Buzzetti E.; Calabria S.; Capeci W.; Caradio F.; Carleo P.; Carrabba M.D.; Castorani L.; Cecchetto L.; Cicco S.; Cimini C.; Colombo B.M.; De Giorgi A.; DeVuono S.; DelCorso L.; Denegri A.; DiGiosia P.; Durante Mangoni E.; Falsetti L.; Forgione A.; Giorgini P.; Grassi D.; Grembiale A.; Hijazi D.; Iamele L.; Lorusso G.; Marchese A.; Marra A.M.; Masala M.; Miceli G.; Montebianco Abenavoli L.; Murgia G.; Naccarato P.; Pattoneri P.; Perego F.; Pesce P.; Piano S.; Pinna M.; Pinto D.; Pretti V.; Pucci G.; Salinaro F.; Salzano A.; Santilli F.; Scarpini F.; Scicali R.; Sirico D.; Suppressa P.; Talia M.; Tassone E.J.; Torres D.; Vazzana N.; Vecchio C.R.; Vidili G.; Vitale F.; Zaccone V.Raparelli, V.; Pastori, D.; Pignataro, S. F.; Vestri, A. R.; Pignatelli, P.; Cangemi, R.; Proietti, M.; Davi, G.; Hiatt, W. R.; Lip, G. Y. H.; Corazza, G. R.; Perticone, F.; Violi, F.; Basili, S.; Alessandri, C.; Serviddio, G.; Palange, P.; Greco, E.; Bruno, G.; Averna, M.; Giammanco, A.; Sposito, P.; Decristofaro, R.; Carulli, L.; Digennaro, L.; Pellegrini, E.; Cominacini, L.; Mozzini, C.; Pasini, A. F.; Sprovieri, M.; Spagnuolo, V.; Cerqua, G.; Cerasola, G.; Mule, G.; Barbagallo, M.; Lo Sciuto, S.; Monteverde, A.; Saitta, A.; Lo Gullo, A.; Malatino, L.; Cilia, C.; Terranova, V.; Pisano, M.; Pinto, A.; Diraimondo, D.; Tuttolomondo, A.; Conigliaro, R.; Signorelli, S.; Depalma, D.; Galderisi, M.; Cudemo, G.; Galletti, F.; Fazio, V.; Deluca, N.; Meccariello, A.; Caputo, D.; Dedonato, M. T.; Iannuzi, A.; Bresciani, A.; Giunta, R.; Utili, R.; Iorio, V.; Adinolfi, L. E.; Sellitto, C.; Iuliano, N.; Bellis, P.; Tirelli, P.; Sacerdoti, D.; Vanni, D.; Iuliano, L.; Ciacciarelli, M.; Pacelli, A.; Palazzuoli, A.; Cacciafesta, M.; Gueli, N.; Lo Iacono, C.; Brusco, S.; Verrusio, W.; Nobili, L.; Tarquinio, N.; Pellegrini, F.; Vincentelli, G. M.; Ravallese, F.; Santini, C.; Letizia, C.; Petramala, L.; Zinnamosca, L.; Minisola, S.; Cilli, M.; Colangelo, L.; Falaschi, P.; Martocchia, A.; Pastore, F.; Bertazzoni, G.; Attalla El Halabieh, E.; Paradiso, M.; Lizzi, E. M.; Timmi, S.; Battisti, P.; Cerci, S.; Ciavolella, M.; Diveroli, C.; Malci, F.; Deciocchis, A.; Abate, D.; Castellino, P.; Zanoli, L.; Fidone, F.; Mannarino, E.; Pasqualini, L.; Oliverio, G.; Pende, A.; Artom, N.; Ricchio, R.; Fimognari, F. L.; Alletto, M.; Messina, S.; Sesti, G.; Arturi, F.; Succurro, E.; Fiorentino, T. V.; Pedace, E.; Scarpino, P. E.; Carullo, G.; Maio, R.; Sciacqua, A.; Frugiuele, P.; Battaglia, G.; Atzori, S.; Delitala, G.; Angelucci, E.; Sestili, S.; Traisci, G.; Defeudis, L.; Dimichele, D.; Fava, A.; Balsano, C.; Deciantis, P.; Desideri, G.; Camerota, A.; Mezzetti, M.; Gresele, P.; Vedovati, C.; Fierro, T.; Puccetti, L.; Bertolotti, M.; Mussi, C.; Boddi, M.; Savino, A.; Contri, S.; Degl'Innocenti, G.; Saller, A.; Fabris, F.; Pesavento, R.; Filippi, L.; Vedovetto, V.; Puato, M.; Treleani, M.; Deluca, E.; Dezaiacomo, F.; Giantin, V.; Semplicini, A.; Minuz, P.; Romano, S.; Fantin, F.; Manica, A.; Stockner, I.; Pattis, P.; Gutmann, B.; Catena, C.; Colussi, G.; Sechi, L. A.; Annoni, G.; Bruni, A. A.; Castagna, A.; Spinelli, D.; Miceli, E.; Padula, D.; Schinco, G.; Spreafico, S.; Secchi, B.; Vanoli, M.; Casella, G.; Pulixi, E. A.; Sansone, L.; Serra, M. G.; Longo, S.; Antonaci, S.; Belfiore, A.; Frualdo, M.; Palasciano, G.; Ricci, L.; Ventrella, F.; Bianco, C.; Santovito, D.; Cipollone, F.; Nicolai, S.; Salvati, F.; Rini, G. B.; Scozzari, F.; Muiesan, M. L.; Salvetti, M.; Bazza, A.; Picardi, A.; Vespasiani-Gentilucci, U.; Devincentis, A.; Cosio, P.; Terzolo, M.; Madaffari, B.; Parasporo, B.; Fenoglio, L.; Bracco, C.; Melchio, R.; Gentili, T.; Salvi, A.; Nitti, C.; Gabrielli, A.; Martino, G. P.; Capucci, A.; Brambatti, M.; Sparagna, A.; Tirotta, D.; Andreozzi, P.; Ettorre, E.; Viscogliosi, G.; Servello, A.; Musumeci, M.; Delfino, M.; Giorgi, A.; Glorioso, N.; Melis, G.; Marras, G.; Matta, M.; Sacco, A.; Stellitano, E.; Scordo, A.; Russo, F.; Caruso, A. A.; Porreca, E.; Tana, M.; Ferri, C.; Cheli, P.; Portincasa, P.; Muscianisi, G.; Giordani, S.; Stanghellini, V.; Sabba, C.; Mancuso, G.; Bartone, M.; Calipari, D.; Arcidiacono, G.; Bellanuova, I.; Ferraro, M.; Marigliano, G.; Cozzolino, D.; Lampitella, A.; Acri, V.; Galasso, D.; Mazzei, F.; Buratti, A.; Galasso, S.; Porta, M.; Brizzi, M. F.; Fattorini, A.; Sampietro, F.; D'Angelo, A.; Manfredini, R.; Pala, M.; Fabbian, F.; Moroni, C.; Valente, L.; Lopreiato, F.; Parente, F.; Granata, M.; Moia, M.; Braham, S.; Rossi, M.; Pesce, M.; Gentile, A.; Catozzo, V.; Baciarello, G.; Cosimati, A.; Ageno, W.; Rancan, E.; Guasti, L.; Ciccaglioni, A.; Negri, S.; Polselli, M.; Prisco, D.; Marcucci, R.; Ferro, D.; Perri, L.; Saliola, M.; Delben, M.; Angelico, F.; Baratta, F.; Migliacci, R.; Porciello, G.; Corrao, S.; Napoleone, L.; Talerico, G.; Amoroso, D.; Romiti, G. F.; Ruscio, E.; Toriello, F.; Sperduti, N.; Todisco, T.; Ditanna, G.; Sacchetti, M. L.; Puddu, P. E.; Farcomeni, A.; Anzaldi, M.; Bazzini, C.; Bianchi, P. I.; Boari, B.; Buonauro, A.; Butta, C.; Buzzetti, E.; Calabria, S.; Capeci, W.; Caradio, F.; Carleo, P.; Carrabba, M. D.; Castorani, L.; Cecchetto, L.; Cicco, S.; Cimini, C.; Colombo, B. M.; De Giorgi, A.; Devuono, S.; Delcorso, L.; Denegri, A.; Digiosia, P.; Durante Mangoni, E.; Falsetti, L.; Forgione, A.; Giorgini, P.; Grassi, D.; Grembiale, A.; Hijazi, D.; Iamele, L.; Lorusso, G.; Marchese, A.; Marra, A. M.; Masala, M.; Miceli, G.; Montebianco Abenavoli, L.; Murgia, G.; Naccarato, P.; Pattoneri, P.; Perego, F.; Pesce, P.; Piano, S.; Pinna, M.; Pinto, D.; Pretti, V.; Pucci, G.; Salinaro, F.; Salzano, A.; Santilli, F.; Scarpini, F.; Scicali, R.; Sirico, D.; Suppressa, P.; Talia, M.; Tassone, E. J.; Torres, D.; Vazzana, N.; Vecchio, C. R.; Vidili, G.; Vitale, F.; Zaccone, V

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease : the ARAPACIS study

Chronic obstructive pulmonary disease (COPD) increases the risk of mortality in non-valvular atrial fibrillation (NVAF) patients. Data on the relationship of COPD to major cardiovascular events (MACE) in AF have not been defined. The aim of the study is to assess the predictive value of COPD on incident MACE in NVAF patients over a 3-year follow-up. In the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study (ARAPACIS) cohort, we evaluate the impact of COPD on the following clinical endpoints: MACE (including vascular death, fatal/non-fatal MI and stroke/TIA), cardiovascular (CV) death and all-cause mortality. Among 2027 NVAF patients, patients with COPD (9%) are more commonly male, elderly and at higher thromboembolic risk. During a median 36.0&nbsp;months follow-up, 186 patients experienced MACE: vascular death (n\u2009=\u200972), MI (n\u2009=\u200957), stroke/TIA (n\u2009=\u200957). All major outcomes (including stroke/TIA, MI, vascular death, and all-cause death) are centrally adjudicated. Kaplan-Meier curves show that NVAF patients with COPD are at higher risk for MACE (p\u2009&lt;\u20090.001), CV death (p\u2009&lt;\u20090.001) and all-cause death (p\u2009&lt;\u20090.001). On Cox proportional hazard analysis, COPD is an independent predictor of MACE (Hazard ratio [HR] 1.77, 95% Confidence Intervals [CI] 1.20-2.61; p\u2009=\u20090.004), CV death (HR 2.73, 95% CI 1.76-4.23; p\u2009&lt;\u20090.0001) and all-cause death (HR 2.16, 95% CI 1.48-3.16; p\u2009&lt;\u20090.0001). COPD is an independent predictor of MACE, CV death and all-cause death during a long-term follow-up of NVAF patients